Octave Bioscience News and Activities

View the org chart displaying its 22 main executives

Most searched biographies at Octave Bioscience

• Doug Biehn, Chief Executive Officer and President
• Lucy Coassin, Director
• William Hagstrom, Chairman of the Board

Popular executive movements at Octave Bioscience

• Zachary Fernandes has joined the company as Vice President, Business Development  (posted on May 27 2026).
• Kirk Stockwood has joined the company as Senior Vice President, Commercial  (posted on January 9 2026).

Create your alert
to follow the executive moves at Octave Bioscience.

Octave Bioscience has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Octave Bioscience

• Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial
• Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States
• Octave Bioscience to Participate in the Piper Sandler 37th Annual Healthcare Conference
• Octave Bioscience to Participate in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
• Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test
• Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum
• Octave Bioscience to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
• Octave Bioscience Expands Medical Leadership to Accelerate Precision Care in Neurodegenerative Disease
• Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care
• Octave® Bioscience, Inc. Announces Publication in Nature Communications
• View more press releases Close

Social media about Octave Bioscience

• Octave Bioscience on Wikipedia, Google News & Yahoo Finance
• Octave Bioscience on LinkedIn, X (Twitter) & YouTube